- Friday 1st of October 2021
Where Can I Find Info On Fildena CT 100 And Use In Prostate Conditions?
You can find credible information on Fildena CT 100 and its use related to prostate conditions from several reliable sources and research studies — but it’s important to understand what’s established and what isn’t:
Official Product & Medical Information Sources
For basic details about Fildena CT 100 — what it is, how it works, and its primary use (treating erectile dysfunction) — product descriptions from manufacturer sites or medical leaflets are useful. These explain that it is a chewable sildenafil citrate tablet used mainly for ED by increasing blood flow to the penis through PDE5 inhibition.
Regulatory & Safety References
Authoritative drug information sites and regulatory labels (e.g., FDA or similar medicine regulatory bodies in your country) can clarify whether the formulation is approved and what indications are officially recognized. Note that many sildenafil generics like Fildena CT 100 may not be FDA-approved in the U.S. even though the active ingredient (sildenafil) is widely studied and approved for certain conditions.
Clinical Research on PDE5 Inhibitors and Prostate-Related Symptoms
While Fildena CT 100 mg itself isn’t specifically approved for prostate conditions, clinical studies have investigated sildenafil (the same active ingredient) in combinations (e.g., with tamsulosin) for symptoms of benign prostatic hyperplasia (BPH)/lower urinary tract symptoms. These studies suggest potential improvement in urinary symptoms and quality of life in men with BPH when sildenafil is added to standard therapy, though results are specific to study contexts and require medical oversight.
Scientific Databases & Research Portals
PubMed (National Library of Medicine) or clinical guideline sites (e.g., urology associations) publish peer-reviewed studies and guideline summaries on PDE5 inhibitors, including topics like ED and lower urinary tract symptoms related to prostate enlargement. Searching terms like “sildenafil PDE5 inhibitor benign prostatic hyperplasia LUTS” on PubMed will lead to relevant clinical trials and reviews.
A urologist or general physician can interpret clinical evidence and tell you whether off-label use of sildenafil for prostate-related issues is appropriate in your specific health situation.
Know more information : genericday.com
Latest News
- Friday 1st of October 2021
“BIZ 2021” Entrepreneurial Day competition
- Friday 1st of October 2021
Workshop on modern assessment and the Use of Zoom Software in Learner-Centered Classroom (Academic staff)
- Friday 19th of March 2021
“Let’s Plant Trees for a Better Environment 2021”
- Friday 19th of March 2021
Biz 2020 – UWU Entrepreneurs’ Day
- Friday 19th of March 2021
Faculty of Management signs MoU with the Sri Lanka Institute of Marketing
- Friday 19th of March 2021
0 Replies:
Leave a Reply